
As of 30-JUN-2026, promoters held 27.91% of Strides Pharma Science (0.00 pp from 31-MAR-2026), foreign institutional investors 28.39%, domestic institutions 15.41%, the government 0.01% and the public 28.28%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Promoters held 27.91% of Strides Pharma Science as of 30-JUN-2026, unchanged from 27.91% in 31-MAR-2026.
Foreign institutional investors held 28.39% of Strides Pharma Science as of 30-JUN-2026, a change of -0.29 pp from the previous quarter.
Domestic institutional investors, including mutual funds and insurers, held 15.41% of Strides Pharma Science as of 30-JUN-2026 (+0.96 pp from the previous quarter).
As of 30-JUN-2026, Strides Pharma Science's shareholders were promoters (27.91%), foreign institutional investors 28.39%, domestic institutions 15.41%, the government 0.01% and the public 28.28%, as filed with the stock exchanges.
Track STAR live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.